PETROBRAS INVESTOR ALERT: $3B Settlement Covers Only US Securities. Majority of International Investors and Losses Not Covered
Stichting Petrobras Compensation Foundation (SPCF or Foundation).
On January 3, 2018, Petrobras announced that in connection with the losses investors suffered from the “Lava Jato” bribery scandal, it had agreed to a USD 2.95 Billion settlement with investors who purchased American Depository Shares (ADS) and bonds in the US. The US settlement is a commendable and positive development, but it only provides recoveries for claims by purchasers in the United States and by purchasers of Petrobras securities that are listed for trading in the United States. The US issued and traded securities represent a limited portion of Petrobras global securities and related investor losses. The majority of investor losses occurred from trading in the Petrobras securities including Preferred and Common shares traded on the Brazilian exchange in São Paulo, European-regulated exchanges and bonds issued by Petrobras Global Finance, which is headquartered in the Netherlands, not in Brazil. The underlying fraud and events are the exact same and Petrobras should treat its investors equally. Petrobras should therefore compensate its investors regardless of which exchange, or in which country, they purchased Petrobras shares or bonds.
In January 2017, SPCF, backed by a coalition of international investors and law firms, started legal action against Petrobras and filed a Writ of Summons in District Court in Rotterdam, seeking declaratory relief for global investors who purchased Petrobras securities in non-US markets or on non-US exchanges.
The litigation in the Netherlands covers the principal Petrobras equity securities that traded on the BOVESPA exchange in São Paulo and via linked markets such as Latibex on Bolsa De Madrid. The litigation in the Netherlands also covers the claims of bondholders whose losses are not included in the US litigation.
A case management hearing took place on August 23, 2017 at the District Court in Rotterdam. Parties are now litigating preliminary issues. The focus of the case is expected to shift to the merits in the Summer of 2018. Any judgment issued by the court in favor of the Foundation, or any earlier settlement with the Foundation relating to investments in international securities (non-US securities), would be enforceable at least throughout Europe.
The Dutch litigation is a result of significant investigations and planning and was formalized in February 2016 by SPCF supported by a coalition of international investors, law firms, litigation funders and investor interest groups, to litigate against Petrobras with the goal of reaching a global binding resolution. The Foundation board is composed of prominent independent legal and finance expert directors, including a former Justice Secretary for the Dutch government and the Foundation’s Chairman Mr. H. TH. (Dick) Bouma, a former Justice at the Court of Appeals in The Hague.
The Foundation has significant support from institutional investors from around the world, including investors in the US, UK, Brazil, Netherlands, France, Germany, Spain, Italy, Nordic countries, Japan and others. Individual institutional investor losses range in the millions, tens of millions and in some instances close to USD 100 million. Investors have signed Foundation support and contingency success fee funding agreements, supporting and demonstrating their desire to pursue restitution for the losses they unfairly and unexpectedly suffered as a result of the illegal acts of Petrobras.
Many of Petrobras’ activities are structured via various entities in the Netherlands (Rotterdam). Petrobras also raises debt capital from investors via its Dutch subsidiary, Petrobras Global Finance B.V. (PGF), headquartered in Rotterdam (not in Brazil). Petrobras has issued an unconditional guarantee towards the debenture holders for the fulfillment of PGF’s obligations. Providing additional nexus to the Netherlands, the Petrobras corruption scandal reached into Holland via a Dutch listed company, SBM Offshore, that allegedly bribed Petrobras executives and ultimately settled with Dutch regulators for USD 240 million, the largest anti-corruption settlement in Dutch corporate history. Petrobras continues significant operations in the Netherlands to this day. Ultimately, the Dutch Collective Settlement Act (WCAM) is a framework that would permit Petrobras to obtain global peace with damaged investors.
Jurjen Lemstra, Partner at Lemstra Van der Korst – the leading law firm representing the Petrobras investors in the Netherlands – commented “Petrobras investors seeking to prosecute claims in Brazil cannot expect an adequate and fair trial, amongst others because the Brazilian system is one with many conflicts of interest. With strong nexus for this case in the Netherlands, the Dutch court system is the optimal international legal environment for the litigation against Petrobras, amongst others because Dutch courts have historically ruled favorably for Foundations representing shareholders, such as SPCF, in large multinational securities fraud collective actions.”
In the past, Petrobras promoted that European investors could elevate their confidence in the Company and its compliance, when it became subject to European regulators, including the Spanish financial markets regulator CNMV, in connection with various arrangements, including its linked-market arrangement with European exchanges, such as Bolsa Madrid, to trade and freely transfer its securities (same securities Cusip/ISIN as traded in Brazil) in custody between Brazil and Europe.
Investors that are interested in joining the action can contact ISAF, the administrative support agent and funding organizer for SPCF at info@isafmanagement.com
Global Coalition Information
Foundation. Stichting Petrobras Compensation Foundation (SPCF) is a Netherlands-based foundation that acts on behalf of damaged Petrobras investors who purchased securities on markets outside of the United States. More information about the Foundation can be found at www.pbcompensation.com
Contingency Investor Funding. SPCF has appointed International Securities Associations & Foundations Management Company for Damaged Petrobras Investors (Bovespa) Ltd. (ISAF) to coordinate with investors. ISAF has organized the funding of all litigation costs so that investors can participate with no upfront cost. More information about ISAF can be found at www.isafmanagement.com
Law Firms. Lemstra Van der Korst N.V., a leading Dutch litigation and class action law firm (Netherlands), acts on behalf of the Foundation and is consulting with securities litigation firms, Motley Rice LLC (US), Lowey Dannenberg Cohen & Hart, P.C. (US), Withers LLP (UK) and certain Brazilian law firms.
Claims Analysis and Processing. Battea Class Action Services, LLC, an international leader in class and collective action damages evaluations securities claims filings, has been retained to collect client data and process and validate investor losses. More information about Battea can be found at www.battea.com
MEDIA CONTACT: Lemstra Van der Korst N.V. / Flip Wijers, f.wijers@lvdk.com / Martijn van Dam, m.vandam@lvdk.com / Jurjen Lemstra, j.lemstra@lvdk.com
More information can be found on: www.lvdk.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180107005129/en/
Contact information
MEDIA:
Lemstra Van der Korst N.V.
Flip Wijers, +31 (20) 2050567
f.wijers@lvdk.com
or
Martijn
van Dam, +31 (20) 2050567
m.vandam@lvdk.com
or
Jurjen
Lemstra, +31 (20) 2050567
j.lemstra@lvdk.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release
Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom